ProAssurance Corporation
NYSE:PRAInsurance - Property & Casualty
+$0.00 today
- Market cap
- $1.29B
- Beta
- 0.04
- P/E (TTM)
- 19.4
- EPS (TTM)
- $1.27
Volume 0.00M
Average 0.93M
PRA Cash & Equivalents
Cash on hand and highly liquid investments that can be converted to cash almost immediately.
ProAssurance CorporationNYSE: PRA
Cash & Equivalents · Q1 FY2026 · quarter ended Mar 2026
Cash & equivalents falls 67.7% from a year ago
Cash & equivalents stood at $14.05M at the end of Q1 FY2026, down 67.7% from a year earlier and down 61.5% from the prior quarter. Over 3 fiscal years it compounded at +6.8% a year.
Context
- Cash & equivalents amounted to 0.3% of total assets at the end of Q1 FY2026, down 0.5 pp from a year earlier.
- Cash & equivalents increased in 1 of the last 3 fiscal years.
What to watch
Whether cash & equivalents keeps falling in the next quarterly balance sheet after a -67.7% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Cash & Equivalents history
USD · from the balance sheet
- Latest · FY2025
- 36.49M USD
- Year-over-year change
- -33.5%
- 4-year CAGR
- -29.0%
| Period | Period end | Cash & Equivalents | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 36.49M | -33.5% |
| FY2024 | 2024-12-31 | 54.88M | -16.7% |
| FY2023 | 2023-12-31 | 65.9M | +120.0% |
| FY2022 | 2022-12-31 | 29.96M | -79.1% |
| FY2021 | 2021-12-31 | 143.6M | — |
Cash & Equivalents vs competitors
How PRA compares with its peers on the latest reported figures
- PRA's Mar 2026 cash & equivalents of $14.05M is the 9th highest of the 11 companies compared; the peer median is $49.55M.
- Its year-over-year change of -67.7% is the 7th highest of 11, against a peer median of -8.2%.
- Cash & equivalents amounts to 0.3% of total assets for PRA, versus a peer median of 2.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $2.06B | +99.8% | +140.5% | 13.7% | |
| Mar 2026 | $608.9M | -0.3% | -3.3% | 39.0% | |
| Mar 2026 | $398.64M | +32.5% | -22.6% | 6.6% | |
| Mar 2026 | $62.34M | -85.2% | -30.5% | 0.6% | |
| Mar 2026 | $54.83M | -15.3% | +42.9% | 2.3% | |
| Mar 2025 | $44.27M | +46.7% | -19.3% | 3.6% | |
| Mar 2026 | $39.47M | -86.5% | -29.9% | 0.3% | |
| Mar 2026 | $23.11M | -1.1% | +74.2% | 3.6% | |
| Mar 2026 | $14.05M | -67.7% | +6.8% | 0.3% | |
| Mar 2026 | $11.14M | -88.6% | +50.1% | 0.4% | |
| Sep 2026 | $928K | -96.2% | -10.7% | 0.0% | |
| Peer median (excluding PRA) | $49.55M | -8.2% | -7.0% | 2.9% | |
Competitors are the stored peer set for PRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 143.6M | 29.96M | 65.9M | 54.88M | 36.49M |
| Short-term Investments | 4.05B | 3.72B | 3.93B | 4.02B | 4.09B |
| Net Receivables | 707.44M | 693.3M | 235.57M | 656.2M | 582.04M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 0 | (4.47B) | 239.79M | (4.58B) | 0 |
| Total Current Assets | 4.93B | 0 | 541.25M | 0 | 4.74B |
| Property, Plant & Equipment (Net) | 19.6M | 18.99M | 46.03M | 16.51M | 13.82M |
| Goodwill | 49.61M | 49.61M | 5.5M | 5.5M | 5.5M |
| Intangible Assets | 73.34M | 66.8M | 60.31M | 54.2M | 105.94M |
| Long-term Investments | 4.64B | 512.69M | 420.78M | 376.56M | 349.71M |
| Tax Assets | 0 | 0 | 186.16M | 0 | 121.87M |
| Other Non-current Assets | 138.11M | (648.09M) | 3.9B | (452.78M) | 106.16M |
| Total Non-current Assets | 4.79B | 0 | 4.62B | 0 | 703.01M |
| Total Assets | 6.19B | 5.7B | 5.63B | 5.57B | 5.45B |
| Account Payables | 22.63M | 28.51M | 24.02M | 27.29M | 14.42M |
| Short-term Debt | 0 | 0 | 3.29M | 125M | 125M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 422.95M | 0 | 418.76M | 403.88M |
| Other Current Liabilities | 3.58B | (451.46M) | 2.93B | 3.26B | 3.02B |
| Total Current Liabilities | 22.63M | 0 | 2.96B | 3.83B | 3.56B |
| Long-term Debt | 424.99M | 426.98M | 427.13M | 299.87M | 295.42M |
| Deferred Tax Liabilities | 0 | 0 | 30.62M | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 4.32B | 226.38M | 619.18M | 226.52M | 226.3M |
| Total Non-current Liabilities | 4.76B | 673.37M | 1.09B | 543.78M | 536.36M |
| Total Liabilities | 4.76B | 4.6B | 4.52B | 4.37B | 4.1B |
| Common Stock | 633K | 634K | 636K | 638K | 640K |
| Retained Earnings | 1.43B | 1.42B | 1.38B | 1.43B | 1.49B |
| Accumulated OCI | 16.28M | (298.61M) | (204.49M) | (172.39M) | (81.05M) |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 1.43B | 1.1B | 1.11B | 1.2B | 1.35B |
| Total Debt | 445.83M | 446.99M | 444.31M | 442.26M | 435.06M |
| Net Debt | 302.23M | 417.03M | 378.41M | 387.38M | 398.57M |
ProAssurance Corporation
NYSE:PRA
Intrinsic Alpha fair value
Locked
Current Price
$25.00
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.